Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Journal of Endocrinology|January 24, 2012
Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitusA H van Lierop, N A T Hamdy, R W van der Meer, et al.Calcified Tissue International|November 23, 2020
Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)M Hagelstein-Rotman, M E Meier, B C J Majoor, et al.European Journal of Endocrinology|January 25, 2011
High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegalyM J E Wassenaar, N R Biermasz, N A T Hamdy, et al.Journal of Dental Research|July 10, 2009
Sclerostin in mineralized matrices and van Buchem diseaseR L van Bezooijen, A L Bronckers, R A Gortzak, et al.Breast (Edinburgh, Scotland)|November 29, 2015
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)A Charehbili, N A T Hamdy, V T H B M Smit, et al.European Journal of Clinical Investigation|June 1, 2007
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteriaP Valent, C Akin, L Escribano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)A Charehbili, S van de Ven, V T H B M Smit, et al.Pageof 4